China Shineway Pharmaceutical Group's low P/E ratio may be d...

China Shineway Pharmaceutical Group's low P/E ratio may be due to market expectations of limited future growth. Investors accept the low P/E, conceding future earnings probably won't provide any pleasant surprises.